BRD4 and hepatocellular carcinoma: An analysis of the survival curves of the mRNA expression of ISX–BRD4 and PCAF–BRD4 indicated that patients with HCC having relatively lower BRD4, whether its ISX or PCAF was high or low, had a significantly shorter survival time.